A PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN IN A PEDIATRIC POPULATION WITH SYMPTOMATIC OBSTRUC
Clinical Trial Grant
Administered By
Pediatrics, Cardiology
Awarded By
Cytokinetics, Inc.
Start Date
January 25, 2025
End Date
September 30, 2028
Administered By
Pediatrics, Cardiology
Awarded By
Cytokinetics, Inc.
Start Date
January 25, 2025
End Date
September 30, 2028